Section Arrow
VRNA.NASDAQ
- Verona Pharma plc
Quotes are at least 15-min delayed:2025/03/28 08:23 EDT
Last
 64.51
+0.33 (+0.51%)
Day High 
66.81 
Prev. Close
64.18 
1-M High
70.4 
Volume 
930.13K 
Bid
64
Ask
67
Day Low
63.5415 
Open
63.68 
1-M Low
59.5 
Market Cap 
5.46B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 65.32 
20-SMA 65.64 
50-SMA 61.42 
52-W High 70.4 
52-W Low 11.39 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.16/2.21
Enterprise Value
5.58B
Balance Sheet
Book Value Per Share
2.41
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
42.28M
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed:2025/03/28 08:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.